Medical innovation and disease burden : conflicting priorities and the social divide in India / Sobin George.

"Striking the right balance between public health priorities and health innovation is a critical policy challenge for India, given their mutually conflicting nature and interests. On the one side, the country has an expanding health industry with a strong presence of domestic and multinational...

Full description

Saved in:
Bibliographic Details
Online Access: Full Text (via Cambridge)
Main Author: George, Sobin (Author)
Format: Electronic eBook
Language:English
Published: Cambridge, United Kingdom ; New York, NY : Cambridge University Press, 2021.
Subjects:

MARC

LEADER 00000cam a2200000 i 4500
001 in00000066510
006 m o d
007 cr |||||||||||
008 201105t20212021enka ob 001 0 eng
005 20230831181719.0
010 |a  2020049873 
035 |a (OCoLC)ceba1204267071 
037 |a ceba9781108832304 
040 |a DLC  |b eng  |e rda  |c DLC  |d OCLCO  |d OCLCF  |d CAMBR  |d YDX  |d EBLCP  |d YDX  |d UKAHL  |d N$T  |d OCLCO  |d OCLCQ 
019 |a 1263780811 
020 |a 9781108935838  |q electronic book 
020 |a 1108935834  |q electronic book 
020 |z 9781108832304  |q hardcover 
020 |a 9781108968225  |q (electronic bk.) 
020 |a 1108968228  |q (electronic bk.) 
020 |z 110883230X 
029 1 |a AU@  |b 000068547673 
035 |a (OCoLC)1204267071  |z (OCoLC)1263780811 
042 |a pcc 
043 |a a-ii--- 
050 0 4 |a RA529  |b .G46 2021 
049 |a GWRE 
100 1 |a George, Sobin,  |e author. 
245 1 0 |a Medical innovation and disease burden :  |b conflicting priorities and the social divide in India /  |c Sobin George. 
264 1 |a Cambridge, United Kingdom ;  |a New York, NY :  |b Cambridge University Press,  |c 2021. 
264 4 |c ©2021 
300 |a 1 online resource (xvi, 210 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
520 |a "Striking the right balance between public health priorities and health innovation is a critical policy challenge for India, given their mutually conflicting nature and interests. On the one side, the country has an expanding health industry with a strong presence of domestic and multinational private firms. The sector, with enormous state facilitation, could effectively position itself as the future engine of economic growth by rearranging itself to the new intellectual property and trade regimes. On the other side, India has a huge burden of diseases implicated by a gamut of public health problems including the uneven distribution of demographic and epidemiological transition, threat of new infectious disease pandemic like COVID-19, increasing privatisation of healthcare, less regulated pharmaceutical market, low affordability to life-saving medicines and most importantly the escalating out-of-pocket healthcare expenditure coupled with poor financial risk protection. All these make the Indian healthscape not only diverse but exceedingly complex as well. Given these, the central question that the book addresses is whether medical innovation in India is sensitive to public health needs and priorities. The book unearths a number of overriding issues related to responsiveness and equity in India's health innovation and highlights the need for a responsible innovation framework for India that balances the priorities of public health and industry goals"--  |c Provided by publisher. 
505 0 |a Cover -- Medical Innovation and Disease Burden -- Title -- Copyright -- Contents -- Tables -- Figures -- Acknowledgements -- Abbreviations -- Introduction -- Medical innovations and public health priorities -- Health R&D in India -- Public health relevance of medical R&D -- 1 Medical Innovation and Its Institutional Co-production in India -- The Indian pharmaceutical industry: sales, export and R&D -- Performance of the biopharmaceutical industry in India -- The Indian medical device/technology sector -- The institutional network of medical innovation 
505 8 |a State, academia and industry linkages in India -- Funding agencies and priority areas in medical innovation -- Partnering institutions for clinical trials -- Conclusion -- Appendix 1A -- 2 The Disease Focus of Health Research and Development -- R&D and disease focus -- Disease focus of R&D in branded generics and biosimilars -- Disease focus of therapeutic and vaccine R&D of biopharmaceuticals in India -- R&D pipeline of major India biopharmaceuticals -- Disease focus of new chemical entity research in India -- Disease focus of medical device/technology R&D in India -- Conclusion -- Appendix 2A 
505 8 |a Brief webnography of selected biopharmaceutical companies -- 3 Drug Development and Responsiveness to Disease Burden -- Causes of deaths in India: a detailed analysis -- Disease-specific mortality -- Morbidity burden of diseases -- Responsiveness of therapeutic drug development to disease burden -- Implications of lower focus on infectious diseases -- Responsiveness of vaccine development to the infectious disease burden -- Conclusion -- 4 Affordability and the Social Divide -- Drug price (de)regulation in India -- The financial burden and affordability of medicines in India 
505 8 |a Price variations of branded drugs -- Price regulation and drug development: ongoing debates -- Value-based pricing and the debate on price reduction in India -- Technological innovation and cost of drugs -- The social divide -- Medicalisation, pharmaceuticalisation and social inequality -- Conclusion -- 5 The Puzzle of Responsive and Responsible Medical Innovation -- Challenges of responsive medical innovation -- Actors, priorities and equity issues -- Policy mismatches -- Responsive and responsible innovation: the way ahead -- Regulation with facilitation -- Balancing the power in global R&D 
588 |a Description based on online resource; title from digital title page (viewed on April 16, 2021). 
650 0 |a Public health  |z India. 
650 0 |a Medical care  |z India. 
650 0 |a Equality  |x Health aspects  |z India. 
650 0 |a Health services accessibility  |z India. 
650 0 |a Medical innovations  |z India. 
650 7 |a Equality  |x Health aspects.  |2 fast  |0 (OCoLC)fst00914463 
650 7 |a Health services accessibility.  |2 fast  |0 (OCoLC)fst00953278 
650 7 |a Medical care.  |2 fast  |0 (OCoLC)fst01013753 
650 7 |a Medical innovations.  |2 fast  |0 (OCoLC)fst01014181 
650 7 |a Public health.  |2 fast  |0 (OCoLC)fst01082238 
651 7 |a India.  |2 fast  |0 (OCoLC)fst01210276 
776 0 8 |i Print version:  |a George, Sobin.  |t Medical innovation and disease burden  |d Cambridge, United Kingdom ; New York, NY : Cambridge University Press, 2021.  |z 9781108832304  |w (DLC) 2020049872 
856 4 0 |u https://colorado.idm.oclc.org/login?url=https://doi.org/10.1017/9781108832304  |z Full Text (via Cambridge) 
915 |a - 
956 |a Cambridge EBA 
956 |b Cambridge EBA ebooks Complete Collection 
998 |b New collection CUP.ebaebookscomplete 
994 |a 92  |b COD 
999 f f |s 78ed3b51-1bc2-482f-a7c6-7979374e3efb  |i 5d799a3f-4c3b-411b-aa6c-2d54c05f5825 
952 f f |p Can circulate  |a University of Colorado Boulder  |b Online  |c Online  |d Online  |h Library of Congress classification  |i web